Literature DB >> 10404956

Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages.

A Okamura1, H Rakugi, M Ohishi, Y Yanagitani, S Takiuchi, K Moriguchi, P A Fennessy, J Higaki, T Ogihara.   

Abstract

BACKGROUND: We have demonstrated that accumulated macrophages in human coronary arteries strongly express angiotensin converting enzyme in accordance with the development of atheromatous plaques. However, there are few reports on the regulation of the renin-angiotensin system in macrophages and in monocytes as their source.
OBJECTIVE: To examine whether the renin-angiotensin system is upregulated during the differentiation of monocytes to macrophages, and whether it is further regulated by angiotensin II and cytokines.
MATERIALS AND METHODS: We used a human leukemia cell line, THP-1, for monocytes. Differentiated THP-1, induced by adding phorbol 12-myristate 13-acetate for 24 h, were used as macrophages. Expression of messenger RNA of the renin-angiotensin system components was measured by quantitative reverse-transcriptase polymerase chain reaction. Angiotensin converting enzyme activity and subtype-specific angiotensin-binding sites of cultured cells, and angiotensin II production in the culture medium were measured.
RESULTS: Macrophages expressed all components of the renin-angiotensin system except chymase. Cellular angiotensin converting enzyme activity and angiotensin II in the medium were increased 3.2- and 4.5-fold during differentiation, respectively. Expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors was increased 6.2-and 6.4-fold during differentiation, and was sustained for 7 days. Incubation with angiotensin II for 24 h caused downregulation of both AT1 and AT2 receptor messenger RNA, but the expression levels were still more than threefold higher compared with monocytes. The density of binding sites of AT1 and AT2 receptors in macrophages was 0.26 +/- 0.02 and 0.15 +/- 0.01 fmol/10(6) cells, respectively.
CONCLUSION: The renin-angiotensin system is markedly activated during monocyte/macrophage differentiation, and may participate in the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404956     DOI: 10.1097/00004872-199917040-00012

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  49 in total

1.  Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

2.  Overexpression of myeloid angiotensin-converting enzyme (ACE) reduces atherosclerosis.

Authors:  Derick Okwan-Duodu; Daiana Weiss; Zhenzi Peng; Luciana C Veiras; Duo-Yao Cao; Suguru Saito; Zakir Khan; Ellen A Bernstein; Jorge F Giani; W Robert Taylor; Kenneth E Bernstein
Journal:  Biochem Biophys Res Commun       Date:  2019-10-12       Impact factor: 3.575

3.  Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis.

Authors:  Masashi Nishida; Hidehiko Fujinaka; Taiji Matsusaka; James Price; Valentina Kon; Agnes B Fogo; Jeffrey M Davidson; MacRae F Linton; Sergio Fazio; Toshio Homma; Hiroaki Yoshida; Iekuni Ichikawa
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

4.  Molecular and Pathophysiological Features of Angiotensinogen: A Mini Review.

Authors:  Congqing Wu; Hong Lu; Lisa A Cassis; Alan Daugherty
Journal:  N Am J Med Sci (Boston)       Date:  2011-10-01

Review 5.  Vitamin D receptor signaling in renal and cardiovascular protection.

Authors:  Yan Chun Li
Journal:  Semin Nephrol       Date:  2013-09       Impact factor: 5.299

6.  Lessons learned from experimental myocarditis.

Authors:  A Matsumori
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

7.  Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth.

Authors:  Kimiyasu Egami; Toyoaki Murohara; Toshifumi Shimada; Ken-Ichiro Sasaki; Satoshi Shintani; Takeshi Sugaya; Masahiro Ishii; Teiji Akagi; Hisao Ikeda; Toyojiro Matsuishi; Tsutomu Imaizumi
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

8.  Vascular wall ACE is not required for atherogenesis in ApoE(-/-) mice.

Authors:  Daiana Weiss; Kenneth E Bernstein; Sebastian Fuchs; Jonathan Adams; Andreas Synetos; W Robert Taylor
Journal:  Atherosclerosis       Date:  2009-10-06       Impact factor: 5.162

9.  Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.

Authors:  Hong Lu; Debra L Rateri; David L Feldman; Richard J Charnigo; Akiyoshi Fukamizu; Junji Ishida; Elizabeth G Oesterling; Lisa A Cassis; Alan Daugherty
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.

Authors:  Li-Jun Ma; Haichun Yang; Ariana Gaspert; Gianluca Carlesso; Melissa M Barty; Jeffrey M Davidson; Dean Sheppard; Agnes B Fogo
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.